Albion Investors
Albion Investors LLC is a private investment firm headquartered in New York, New York, founded in 1995. The firm specializes in private equity and debt investments, focusing on lower middle-market companies. Albion primarily engages in leveraged buyouts, growth equity investments, and mezzanine financing, targeting industries such as value-added distribution, specialty manufacturing, business services, consumer goods, and media. The firm typically invests between $5 million and $30 million in debt and $3 million and $15 million in equity, with an emphasis on companies that have an EBITDA exceeding $4 million. Albion seeks to take lead positions in micro-cap deals, with investments ranging from $5 million to $20 million, while also co-investing in larger enterprises with valuations between $20 million and $1 billion. The firm's investment strategy includes acquiring majority and minority stakes and obtaining board seats in its portfolio companies. Albion Investors has managed over $2.7 billion in client capital, primarily for institutional and family-office investors.
Helveta
Venture Round in 2010
Helveta Ltd develops technology products for the timber and food sectors. It offers The CI World platform, an interactive cartography application that provides auditable traceability, asset tracking, resource and forest use mapping, and chain of custody control for extended supply chains; and allows monitoring logging activities, and to export data points and associated icons to GIS products enabling the online sharing of maps among communities over the Web. The company serves growers, farm managers, agronomists, and buyers. Helveta Ltd was incorporated in 2004 and is based in Oxford, the United Kingdom with operations in Nigeria, the Central African Republic, the Republic of Congo, and Cameroon.
Xceleron
Venture Round in 2010
Xceleron, founded in 1997 in York, UK, and now based in Germantown, Maryland, specializes in bioanalytical accelerator mass spectrometry (AMS) services to enhance drug development. The company pioneered techniques for human microdosing and microtracing, focusing on the pharmacokinetics and metabolism of developmental drugs during early clinical trial phases. Xceleron's services include micro-dosing, preclinical evaluation, intravenous pharmacokinetics, metabolite profiling, and mass balance investigations in humans. Their expertise is particularly valuable given the complexity of modern small molecules, which often exhibit low solubility and lengthy half-lives, necessitating early pharmacokinetic characterization to improve the cost-effectiveness of clinical development. Through a commitment to integrity and collaboration, Xceleron aims to accelerate the delivery of life-changing products to the market.
Osterman Propane
Series C in 2008
Osterman Propane is a provider of propane gas utilities catering to residential, commercial, and industrial clients. Founded in New England, the company has a legacy of over fifty years in delivering efficient propane gas and heating services. It was formed from the merger of Bay State Propane and Northern Propane, both of which were longstanding affiliates of Bay State Gas and Northern Utilities. Osterman Propane focuses on delivering quality services at competitive prices, ensuring that its clients receive reliable energy solutions tailored to their needs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.